| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |